TP53 and central nervous system cancer: Notably, p28 peptide, an anti-glioma drug, specifically dampens the COP1-p53 binding and stabilizes p53 from degradation31, and our structural analyses showed that there are overlaps between azurin binding sites and reported ubiquitin E3 ligase COP1 binding sites on p5314,32.